Coagulation analyzers are mainly applied for laboratory tests of thrombosis and hemostasis, which can provide valuable indicators for the diagnosis and differential diagnosis of hemorrhagic and thrombotic diseases, detection, and efficacy of thrombolytic and anticoagulant therapy.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Danaher Corporation announced that it has entered into a definitive agreement with General Electric to acquire GE Life Sciences GE Biopharma business with a cash purchase price of approximately $21.4 billion. Given the expected tax benefits

Icon, an international drug-development and commercialization services firm, has acquired MolecularMD for an undisclosed amount, the companies said recently. MolecularMD, based in Portland, Oregon, is a molecular diagnostic laboratory that s

Exact Sciences reported after the close of the market recently that its fourth quarter revenues rose 64 percent year over year, thanks to a 66 percent increase in the number of completed Cologuard colorectal cancer tests during the quarter.

GenMark Diagnostics reported after the close of the market recently that its fourth quarter revenues rose 21 percent year over year,in line withpreliminary Q4 revenuesreported in January. For the three months ended Dec. 31, 2018, the company

Agilent Technologies reported after the close of the market on Wednesday that its first quarter 2019 revenues rose 6 percent year over year, thanks largely to a 13 percent increase in revenues in its diagnostics and genomics business. For th

Thermo Fisher Scientific today reported an 8 percent increase in fourth quarter revenues, driven by growth across its four business segments. The company, headquartered in Waltham, Massachusetts, reported Q4 revenues of $6.51 billion, up 8 p

Thermo Fisher Scientific has acquired a 9 percent stake in molecular diagnostic company Yourgene Health by exercising warrants it held in the company. In addition, Thermo Fisher has further warrants that, if exercised, could take its ownersh

PerkinElmer announced after the close of the market on Thursday that its fourth quarter revenues rose 18 percent year over year. For the three months ended Dec. 30, 2018, the company posted revenues of $756.3 million compared to $641.6 milli

The global in vitro diagnostics market was valued at USD 55.00 million in 2016 and is projected to grow at a healthy CAGR of 5.60% between 2017 and 2025 to reach USD 89.8 million by the end of 2025. The market growth will be driven by the ri

Bio-Rad Laboratories has received clearance from the US Food and Drug Administration for its first liquid biopsy assay and Droplet Digital PCR system for diagnostic use, the firm announced today. The test is designed for monitoring treatment